title: Enucleation for gastrointestinal stromal tumors at the esophagogastric junction: is this an adequate solution?
abstract: The authors discussed the proposal by Coccolini and colleagues to treat gastrointestinal stromal tumors (GISTs) at the esophagogastric junction with enucleation and, if indicated, adjuvant therapy, reducing the risks related to esophageal and gastroesophageal resection. They concluded that, because the prognostic impact of a T1 high-mitotic rate on esophageal GIST is worse than that of a T1 high-mitotic rate on gastric GIST, enucleation may not be an adequate surgery for esophagogastric GISTs with a high mitotic rate in which the guarantee of negative resection margins and adjuvant therapies can be the only chance of survival.
authors.forename: Nadia
authors.initials: N
authors.lastname: Peparini
authors.forename: Giovanni
authors.initials: G
authors.lastname: Carbotta
authors.forename: Piero
authors.initials: P
authors.lastname: Chirletti
mesh_terms: D004943:Esophagogastric Junction / Q000473:pathology* / Q000601:surgery*; D046152:Gastrointestinal Stromal Tumors / Q000601:surgery*; D006801:Humans; D015996:Survival Rate; D016896:Treatment Outcome